What Challenges Exist in Developing Universal Vaccines Using Nanotechnology?
Despite the promising potential of nanotechnology in vaccine development, several challenges remain:
Safety and Biocompatibility: Ensuring that nanoparticles are safe and do not elicit adverse reactions is crucial. Manufacturing and Scalability: Producing nanoparticles at scale while maintaining consistency and quality can be challenging. Regulatory Hurdles: Regulatory agencies have stringent requirements for approving new vaccine technologies, which can slow down the development process. Cost: The development and production of nanoparticle-based vaccines can be expensive, potentially limiting access in low-resource settings.
